Mirum Pharmaceuticals, Inc. (MIRM) vs Oruka Therapeutics, Inc. (ORKA)
Mirum Pharmaceuticals, Inc. and Oruka Therapeutics, Inc. are both Biotechnology companies. Mirum Pharmaceuticals, Inc. and Oruka Therapeutics, Inc. are of similar size ($5.8B and $5.7B). Oruka Therapeutics, Inc. has the higher net margin (0.00% vs −139.2%) and the higher return on invested capital (−40.2% vs −173.0%). Across the 13 metrics below, Oruka Therapeutics, Inc. leads on 9 and Mirum Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | MIRM | ORKA | Biotechnology median |
|---|---|---|---|
| Gross margin | 81.72% | 0.00% | 65.16% |
| Operating margin | (134.93%) | 0.00% | 0.00% |
| Net margin | (139.18%) | 0.00% | 0.00% |
| Free cash flow margin | (44.29%) | 0.00% | 0.00% |
| Return on equity | (702.97%) | (18.30%) | (57.72%) |
| Return on assets | (97.15%) | (17.76%) | (49.22%) |
| Return on invested capital | (172.96%) | (40.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack